Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CCME GlobalBOM:514336 -5.00%26 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates BOM:514336 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 702 Biotechnology companies, CCME Global ranks worse than 142450% on this metric.
The historical rank and industry rank for CCME Global's Days Payable or its related term are showing as below:
During the past 13 years, CCME Global's highest Days Payable was 54.69. The lowest was 54.69. And the median was 54.69.
BOM:514336's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.1 * Ranked among companies with meaningful Days Payable only.
CCME Global's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
CCME Global Days Payable Related Terms
CCME Global Days Payable Historical Data
* Premium members only.
The historical data trend for CCME Global's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:514336 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, CCME Global's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CCME Global Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CCME Global's Days Payable distribution charts can be found below:
* The bar in red indicates where CCME Global's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CCME Global's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CCME Global (BOM:514336) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CCME Global and its competitors. Over the past decade, CCME Global's Days Payable has ranged from 54.69 to 54.69. According to the industry distribution chart, CCME Global ranks #999999 out of 702 companies in the Biotechnology industry.
Is CCME Global's Days Payable too high?
CCME Global's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 54.69 to a high of 54.69. Based on the distribution chart, CCME Global ranks #999999 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CCME Global has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does CCME Global's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CCME Global ranks #999999 out of 702 companies for Days Payable. This places CCME Global in the lower half of its industry. The industry median Days Payable is 113.10. Historically, CCME Global's own Days Payable has ranged from 54.69 to 54.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CCME Global and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CCME Global's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CCME Global stock overvalued right now?
CCME Global (BOM:514336) has a current Days Payable of 0.00. The current Days Payable is 0.00. CCME Global's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CCME Global (BOM:514336), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CCME Global Ltd, formerly known as Genesis IBRC India Ltd, is a manufacturer and supplier of Aqua, poultry, veterinary and agriculture products. The product profile promotes health and illness prevention in Aquaculture, poultry and veterinary.
26GF Score
Get the complete analysis for BOM:514336
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:514336 has been successfully added to your 
